Luba has been working at the 3D Organ Engineering Initiative since 2018 and is leading a Wyss Validation Project aiming to fabricate vascularized functional tissues for transplantation. Her interest is in tissue and organ engineering, focusing on vascularization and implantation studies utilizing complex surgical models. Her background is in molecular biology, pharmacology, and biomedical engineering. Luba also has industry experience in a vascular gene therapy company (MGVS, now VESSL Therapeutics).
Luba Perry, Ph.D.
Senior Scientist II